ICCVAM Public Forum: May 2022
Webcast: May 26-27, 2022
ICCVAM’s goals include promotion of national and international partnerships between governmental and nongovernmental groups, including academia, industry, advocacy groups, and other key stakeholders. To foster these partnerships ICCVAM holds annual public forums to share information and facilitate direct communication of ideas and suggestions from stakeholders. At the 2022 public forum, representatives of ICCVAM member agencies described activities both to advance new approaches to safety testing of chemicals and medical products and to reduce the amount of testing required.
Video: Day 1 Morning Session (approx. 2 hr 19 min)
Video: Day 1 Afternoon Session Part 1 (approx. 1 hr 26 min)
Video: Day 1 Afternoon Session Part 2 (approx. 1 hr 8 min)
Video: Day 2 (approx. 2 hr 19 min)
Presentations
Welcome and Introductions: Anna Lowit, EPA, ICCVAM Co-chair
Consumer Product Safety Commission Guidance on New Approach Methodologies: John Gordon, CPSC
USDA Animal Welfare Information Center: Jessie Carder, USDA
EPA Activities on NAMs: Update from the Office of Pesticide Programs: Monique Perron, EPA Office of Pesticide Programs
EPA Office of Research and Development: Update on Alternatives Research Activities: Alison Harrill, EPA Office of Research and Development
Regulatory Science Tools for Accelerating Innovation in Toxicology Reviews: Edward Margerrison, FDA Center for Devices and Radiological Health
FDA Update on Advancing Alternatives for Regulatory Use: David Strauss, FDA Center for Drug Evaluation and Research
OECD Test Guidelines Programme Update: Charles Kovatch, EPA
3Rs Assessment of Animal Toxicity Data: Steve Hwang, DOT Pipeline and Hazardous Material Adminstration
Carcinogenicity Testing for the 21st Century: Warren Casey, NIEHS
Activities of the Developmental Neurotoxicity Health Effects Innovation Program: Helena Hogberg, NIEHS
Microphysiological Systems Applications for Predictive Toxicology: Tyler Goralski, U.S. Army Combat Capabilities Development Command Chemical Biological Center
Investigating DNA Adduct Formation by Flavor Chemicals and Tobacco Byproduct in E-cigarettes Using In Silico Approaches: Jueichuan (Connie) Kang, FDA Center for Tobacco Products
EPA Activities on New Approach Methods: Update from the Office of Pollution Prevention and Toxics: Anna Lowit, EPA Office of Pollution Prevention and Toxics
NICEATM Update: Nicole Kleinstreuer, NIEHS
ICCVAM Workgroup Updates: David Allen, Inotiv (contractor supporting NICEATM)
Measurement Science in ICCVAM: Elijah Petersen, National Institute of Standards and Technology
Cardiovascular Health Effects Innovation Program Update: Brandy Beverly, NIEHS
Public Comments Presented During Meeting
- Elizabeth Baker, Physicians Committee for Responsible Medicine
- Jessica Ryman-Rasmussen, American Chemistry Council
- Katherine Groff, People for the Ethical Treatment of Animals
Presentation: Comments for People for the Ethical Treatment of Animals - Jay Sirois, Consumer Healthcare Products Association
- Vicki Katrinak, Humane Society of the United States/Humane Society Legislative Fund
Public Comments
Physicians Committee for Responsible Medicine (May 23)
Humane Society of the United States/Humane Society Legislative Fund (May 20)
People for the Ethical Treatment of Animals (May 20)
American Chemistry Council (May 17)
Jean Public (May 9)